Matteo Armillotta

1.6k total citations · 3 hit papers
29 papers, 457 citations indexed

About

Matteo Armillotta is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matteo Armillotta has authored 29 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matteo Armillotta's work include Acute Myocardial Infarction Research (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Cardiovascular Function and Risk Factors (5 papers). Matteo Armillotta is often cited by papers focused on Acute Myocardial Infarction Research (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Cardiovascular Function and Risk Factors (5 papers). Matteo Armillotta collaborates with scholars based in Italy, United States and Belgium. Matteo Armillotta's co-authors include Carmine Pizzi, Luca Bergamaschi, Alberto Foà, Pasquale Paolisso, Gianni Casella, Francesco Angeli, Angelo Sansonetti, Sara Amicone, Andrea Stefanizzi and Nazzareno Galiè and has published in prestigious journals such as European Heart Journal, Pharmacology & Therapeutics and European Journal of Endocrinology.

In The Last Decade

Matteo Armillotta

22 papers receiving 452 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

2022 125 citations Pasquale Paolisso, Luca Bergamaschi et al. Cardiovascular Diabetology profile →
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure

2025 26 citations Matteo Armillotta, Emanuel Raschi et al. Pharmacology & Therapeutics profile →
Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials

2025 14 citations Sara Amicone, Milena Leo et al. European Heart Journal - Cardiovascular Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matteo Armillotta Italy	10	247	166	108	103	69	29	457
Alberto Foà Italy	11	448 1.8×	188 1.1×	102 0.9×	139 1.3×	51 0.7×	48	656
Hongya Han China	14	271 1.1×	103 0.6×	65 0.6×	181 1.8×	86 1.2×	49	535
Sida Jia China	11	202 0.8×	97 0.6×	46 0.4×	141 1.4×	56 0.8×	35	372
Shafik Khoury Israel	13	260 1.1×	37 0.2×	74 0.7×	81 0.8×	36 0.5×	48	443
Bernardino Tuccillo Italy	16	469 1.9×	61 0.4×	155 1.4×	183 1.8×	62 0.9×	55	645
Mengyue Yu China	14	221 0.9×	113 0.7×	80 0.7×	164 1.6×	77 1.1×	29	430
J VEINOT Canada	7	382 1.5×	39 0.2×	157 1.5×	118 1.1×	49 0.7×	10	512
Michele Mattia Viscusi Italy	11	385 1.6×	44 0.3×	88 0.8×	156 1.5×	70 1.0×	50	563
Michał Marchel Poland	16	434 1.8×	41 0.2×	36 0.3×	80 0.8×	54 0.8×	76	683
Giorgio Faganello Italy	14	418 1.7×	50 0.3×	128 1.2×	84 0.8×	53 0.8×	44	519

Countries citing papers authored by Matteo Armillotta

Since Specialization

Citations

This map shows the geographic impact of Matteo Armillotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Armillotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Armillotta more than expected).

Fields of papers citing papers by Matteo Armillotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Armillotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Armillotta. The network helps show where Matteo Armillotta may publish in the future.

Co-authorship network of co-authors of Matteo Armillotta

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Armillotta. A scholar is included among the top collaborators of Matteo Armillotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Armillotta. Matteo Armillotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armillotta, Matteo, Emanuel Raschi, Guido Di Dalmazi, et al.. (2025). Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure. Pharmacology & Therapeutics. 270. 108861–108861. 26 indexed citations breakdown →

Leo, Milena, Marco Basile, Francesco Angeli, et al.. (2025). Cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries (MINOCA): current and evolving perspectives. Expert Review of Cardiovascular Therapy. 23(12). 765–775.

Gambineri, Alessandra, Silvia De Rosa, E. Belardinelli, et al.. (2025). Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrome. European Journal of Endocrinology. 192(3). 210–219. 3 indexed citations

Amicone, Sara, Milena Leo, Marco Basile, et al.. (2025). Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials. European Heart Journal - Cardiovascular Pharmacotherapy. 11(5). 441–450. 14 indexed citations breakdown →

Armillotta, Matteo, Luca Bergamaschi, Pasquale Paolisso, & Carmine Pizzi. (2023). Editorial commentary: Beyond coronary anatomy in acute myocardial infarction: Could stress hyperglycemia ratio be a new prognostic index and therapeutic target?. Trends in Cardiovascular Medicine. 34(7). 466–467. 2 indexed citations

Armillotta, Matteo, Francesco Angeli, Luca Bergamaschi, et al.. (2023). Unifying Diagnosis Explaining Multiorgan Clinical Manifestations: The Unique Case of Antiphospholipid Syndrome Leading to MINOCA. Circulation Cardiovascular Imaging. 16(8). e015371–e015371.

Armillotta, Matteo, Sara Amicone, Luca Bergamaschi, et al.. (2023). Predictive value of Killip classification in MINOCA patients. European Journal of Internal Medicine. 117. 57–65. 23 indexed citations

Angeli, Francesco, Michele Fabrizio, Pasquale Paolisso, et al.. (2022). Classificazione, caratteristiche cliniche e strategie diagnostiche delle masse cardiache. Giornale italiano di cardiologia. 23(8). 620–630. 1 indexed citations

Paolisso, Pasquale, Luca Bergamaschi, Gaetano Santulli, et al.. (2022). Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovascular Diabetology. 21(1). 77–77. 125 indexed citations breakdown →

10.

Sansonetti, Angelo, Luca Bergamaschi, Gaetano Santulli, et al.. (2022). 866 INFARCT SIZE, INFLAMMATORY BURDEN AND ADMISSION HYPERGLYCEMIA IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH SGLT2-INHIBITORS: A MULTICENTER INTERNATIONAL REGISTRY. European Heart Journal Supplements. 24(Supplement_K). 3 indexed citations

11.

Paolisso, Pasquale, Alberto Foà, Luca Bergamaschi, et al.. (2021). Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA. Cardiovascular Diabetology. 20(1). 192–192. 62 indexed citations

12.

Paolisso, Pasquale, Alberto Foà, Luca Bergamaschi, et al.. (2021). Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovascular Diabetology. 20(1). 33–33. 82 indexed citations

13.

Impellizzeri, Andrea, Nicole Suma, Francesco Palermo, et al.. (2021). 742 Myocarditis after SARS-CoV-2 vaccine: is that so simple?. European Heart Journal Supplements. 23(Supplement_G).

14.

Grani, Giorgio, Dario Tumino, Valeria Ramundo, et al.. (2019). Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments. Journal of Endocrinological Investigation. 42(12). 1485–1490. 6 indexed citations

15.

Macarini, Luca, Silvana Muscarella, Luca Pio Stoppino, et al.. (2010). Rotator cable at MR imaging: considerations on morphological aspects and biomechanical role. La radiologia medica. 116(1). 102–113. 16 indexed citations

16.

Costanzo, Alfonso Di, Francesca Trojsi, G.M. Giannatempo, et al.. (2008). Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. La radiologia medica. 113(1). 134–143. 26 indexed citations

17.

Scarabino, Tommaso, Teresa Popolizio, G.M. Giannatempo, et al.. (2007). 3.0-T morphological and angiographic brain imaging: a 5-years experience. La radiologia medica. 112(1). 82–96. 5 indexed citations

18.

Simeone, Adalberto L., Alessandro Carriero, Matteo Armillotta, et al.. (1997). Spiral CT angiography in the study of the carotid stenoses.. PubMed. 24(1). 18–22. 26 indexed citations

19.

Scarabino, Tommaso, et al.. (1995). La sequenza Fast Spin Echo nello studio del distretto spinale. Rivista di Neuroradiologia. 8(5). 675–684.

20.

Armillotta, Matteo, et al.. (1986). [Present role of diagnostic imaging in the study of extensive pathology of the parotid gland].. PubMed. 72(5). 291–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact